Back to results
US 2025/0152553 A1Published application
Carbamothioate, and carbamodithioate derivatives of mdma, mda or its optically active (r)- or (s)-mdma and mda isomers
OwnerTanweer A. KHAN, Glenn SHORT +1inventors
InventorsTanweer A. KHAN, Glenn SHORT, Robert B. PERNI
Life of this patent
Estimating the term…
Abstract
Provided herein are carbamothioate and carbamodithioate derivates of 3,4-methylenedioxymethamphetamine, (R)-3,4-methylenedioxymethamphetamine and (S)-3,4-methylenedioxymethamphetamine.
Claims49
A compound of Formula (VI):
- wherein X1 and X2 are independently O, S, or N;
- R1, R2, R3, and R4 are independently hydrogen, deuterium, alkyl, deuterated alkyl, CH2D, CHD2, CD3, cycloalkyl, halogen, heteroatom-substituted or halogen-substituted alkyl or cycloalkyl, aryl, or heteroaryl;
- and
- R5 and R6, are independently hydrogen, deuterium, CH2D, CHD2, CD3, or a C1 to C6 alkyl.
1 more element
A composition comprising a pharmaceutical carrier and a compound of Formula (VI):
- wherein X1 and X2 are independently O, S, or N;
- R1, R2, R3, and R4 are independently hydrogen, deuterium, alkyl, deuterated alkyl, CH2D, CHD2, CD3, cycloalkyl, halogen, heteroatom-substituted or halogen-substituted alkyl or cycloalkyl, aryl, or heteroaryl;
- and
- R5 and R6, are independently hydrogen, deuterium, methyl, ethyl, CH2D, CHD2, CD3, or a C1 to C6 alkyl.
1 more element
Dependencies are inferred from the claim text.